Severe Aplastic Anaemia Working Party (SAAWP)
Study number:
8409077
Type of Stem Cell Treatment:
Short title:
ATG in aPRCA
Primary objective:
To investigate the effectivity of treatment with ATG in patients with acquired PRCA.
Key inclusion criteria:
Patients are eligible if:
1) they have been diagnosed with acquired PRCA and
2) received ATG treatment between 2000 and 2018.
1) they have been diagnosed with acquired PRCA and
2) received ATG treatment between 2000 and 2018.
Country:
Principal investigator:
Stijn Halkes
EBMT Study coordinator:
Brian Piepenbroek
Study coordinator email:
saawpebmt@lumc.nl